# Remyelination therapies are achievable in clinical practice—Commentary

**Authors:** Anna Karin Hedström

PMC · DOI: 10.1177/13524585251396267 · Multiple Sclerosis (Houndmills, Basingstoke, England) · 2025-12-04

## Full-text entities

- **Diseases:** ORCID iD (MESH:C535742), axonal degeneration (MESH:D009410), loss (MESH:D016388), demyelination (MESH:D003711), MS (MESH:D009103), gliosis (MESH:D005911), inflammatory disease (MESH:D007249), Alzheimer's disease (MESH:D000544)
- **Chemicals:** water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756511/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12756511/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756511/full.md

---
Source: https://tomesphere.com/paper/PMC12756511